Cardiologist: Spike proteins generated by COVID-19 vaccines are 'toxic' to heart

Cardiologist: Spike proteins generated by COVID-19 vaccines are ‘toxic’ to heart

A pediatric cardiologist says it’s now clear from all available evidence that the advanced proteins that COVID-19 vaccines tell the body to make are toxic to the heart, and that myocarditis in young people is not isn’t as rare as the CDC and FDA have made it out to be. leads Americans to believe.

At a lecture on Aug. 26, Dr. Kirk Milhoan said the damage to the heart caused by spike proteins is an “inconvenient truth.”

“We know that spike protein is cardio-toxic. [It’s] very clear that it is cardio-toxic,” he said.

Milhoan, a board-certified pediatric cardiologist, based his conclusion on data from the Vaccine Adverse Event Reporting System (VAERS) and several recently published studies on myocarditis. He thinks myocarditis caused by COVID-19 vaccines isn’t as rare as the government has led Americans to believe.

“We’re seeing something we’ve never seen before,” he said Aug. 26 at the Gateway to Freedom conference in Collinsville, Illinois. “We haven’t seen a vaccine cause this level of myocarditis. It’s not a here or a there. It’s a large number of people who get myocarditis from this vaccine.

Myocarditis, defined as inflammation of the heart muscle, is one of the only serious side effects of the vaccine that has been publicly acknowledged by the FDA and CDC, with the CDC’s most recent guidance repeating what the agency has since said. 2021, that there is only a “rare” risk of myocarditis and pericarditis that has been observed after one of the mRNA vaccines.

Pericarditis is an inflammation of the lining of the heart.

“Rare cases of myocarditis and pericarditis have occurred most commonly, but not exclusively, in adolescent and young adult males within the first week after receiving the second dose or a booster dose of a vaccine to COVID-19 mRNA,” a CDC advisory from May 2021 states.

In his Aug. 26 speech, Milhoan said evidence shows that infection with SARS-CoV-2 likely results in the smallest exposure to the spike protein. In contrast, mRNA vaccines cause the body to produce spike proteins for an unknown period of time, possibly indefinitely.

Damage to the heart caused by myocarditis can be overlooked, he said, citing a study published in the Journal of the American Medical Association (JAMA). The study looked at Big Ten college athletes with a recent diagnosis of COVID-19 and found that 37 of 1,597 athletes studied had myocarditis on cardiovascular magnetic resonance (CMR) imaging. Only half showed heart problems with other testing methods, including electrocardiograms and measuring troponin levels.

Regarding vaccine-related heart problems, he cited a recent peer-reviewed study of 301 adolescents aged 13 to 18 from two schools in Thailand who received a second dose of the Pfizer-BioNTech vaccine.

Baseline echocardiography and cardiac enzyme data were collected before the second dose of vaccine was given and collected again on days 3, 7, and 14 after adolescents received the second dose of vaccine.

Of the 301 adolescents, almost 8% suffered from tachycardia (rapid heartbeat) after the second dose of the Pfizer-BioNTech vaccine; 7% had shortness of breath, 4% had heart palpitations, 4% had chest pain and 4% had hypertension.

In total, cardiovascular problems were found in 29% of adolescents. Two had suspected pericarditis and four had suspected “subclinical myocarditis”. One had a confirmed case of myopericarditis.

In a third study cited by Milhoan, from Denmark, a second dose of the Moderna vaccine appeared to result in a significantly higher rate of myocarditis and pericarditis than the first doses of the Moderna and Pfizer-BioNTech vaccines or a second dose of the Pfizer-BioNTech vaccine.

The study involved 4,931,771 people aged 12 and older who were followed for 28 days after vaccination. During follow-up, 269 participants developed myocarditis or myopericarditis, 73% of them male.

Of the 3,482,295 people who received the Pfizer-BioNTech vaccine, 48 developed myocarditis or myopericarditis within 28 days, or 1.4 per 100,000 people, compared to a baseline rate of unvaccinated people.

Of the 498,814 people who received the Moderna vaccine, 21 developed myocarditis or myopericarditis, a rate of 4.2 per 100,000 people.

“It’s a very interesting story because the Pfizer product contains about one-third of the mRNA the body uses to produce the spike protein,” Milhoan said. “La Moderna has about three times as many.”

He said it “suggests causation, not just correlation.”

On August 31, the FDA announced that it had cleared for emergency use the new bivalent booster vaccines (targeting the latest omicron subvariants as well as the original virus) for 12-year-olds. and over for the Pfizer-BioNTech vaccine and 18 and over for the Modern Vaccine.

The CDC approved the vaccines Sept. 1 following a presentation reviewing safety data from VAERS, V-SAFE, a smartphone-based reporting tool, and the Vaccine Safety Data Link (VSD), which includes data from several major health maintenance organizations in the United States.

While the FDA and CDC have often referred to many cases of post-vaccination myocarditis as “mild,” Milhoan said that word is often taken out of context by government regulators.

“Is there mild myocarditis? Yes, there are,” he said. “When a patient is admitted to intensive care, we do an echocardiogram, we look at the labs, we look at additional studies and we say, ‘Does this look like a mild case, a moderate case or a severe case? ‘”

The mild category, he said, is a term doctors use to compare with more severe cases where a heart transplant might be needed.

“What I explain to families, though,” he said, “if your child has to go to pediatric intensive care (intensive care unit), that doesn’t feel benign to you, although I could call it benign .

According to the OpenVAERS website, there were 8,756 reports in the United States of myocarditis and pericarditis following a COVID-19 vaccination as of August 26.

At a Sept. 1 meeting of the CDC’s advisory committee on immunization practices, CDC employee Tom Shimabukuro said there were 188.2 confirmed cases of myocarditis per 1 million doses of vaccines. given to men aged 12 to 39.

The age group with the highest number of CDC-confirmed cases was males ages 16-17, with 78.7 cases of myocarditis per 1 million doses of Moderna and Pfizer-BioNTech vaccines.

“It is unethical to give a child a vaccine and give them myocarditis if they may not have had myocarditis from a natural infection or if they have been infected before,” said Milhoan to the public on August 26, referring to the Hippocratic oath: “First do no harm.”

“The question is why would we put children at risk if their risk of COVID is very low?” He asked.


#Cardiologist #Spike #proteins #generated #COVID19 #vaccines #toxic #heart

Leave a Comment

Your email address will not be published.